Cargando…

Use of antiviral drugs to reduce COVID-19 transmission

Detalles Bibliográficos
Autores principales:	Mitjà, Oriol, Clotet, Bonaventura
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Author(s). Published by Elsevier Ltd. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104000/ https://www.ncbi.nlm.nih.gov/pubmed/32199468 http://dx.doi.org/10.1016/S2214-109X(20)30114-5

Ejemplares similares

Transmission of COVID-19 in 282 clusters in Catalonia, Spain: a cohort study
por: Marks, Michael, et al.
Publicado: (2021)

Syphilis vaccine: challenges, controversies and opportunities
por: Ávila-Nieto, Carlos, et al.
Publicado: (2023)

Association between two mass-gathering outdoor events and incidence of SARS-CoV-2 infections during the fifth wave of COVID-19 in north-east Spain: A population-based control-matched analysis
por: Suñer, Clara, et al.
Publicado: (2022)

Re-examining the importance of mask-wearing at mass gathering events—Authors' reply
por: Suñer, Clara, et al.
Publicado: (2022)

On the steps of cell-to-cell HIV transmission between CD4 T cells
por: Puigdomènech, Isabel, et al.
Publicado: (2009)

SARS-CoV-2 Infection Modulates ACE2 Function and Subsequent Inflammatory Responses in Swabs and Plasma of COVID-19 Patients
por: Gutiérrez-Chamorro, Lucía, et al.
Publicado: (2021)

Use of Antiviral Drugs to Reduce Household Transmission of Pandemic (H1N1) 2009, United Kingdom
por: Pebody, Richard G., et al.
Publicado: (2011)

Can Antiviral Drugs Contain Pandemic Influenza Transmission?
por: Becker, Niels G., et al.
Publicado: (2011)

Towards antiviral polymer composites to combat COVID‐19 transmission
por: Mouritz, Adrian P., et al.
Publicado: (2021)

Reducing Influenza Virus Transmission: The Potential Value of Antiviral Treatment
por: Hayden, Frederick G, et al.
Publicado: (2021)

A Cost-Benefit Analysis of the COVID-19 Asymptomatic Mass Testing Strategy in the North Metropolitan Area of Barcelona
por: López Seguí, Francesc, et al.
Publicado: (2021)

Tissue distributions of antiviral drugs affect their capabilities of reducing viral loads in COVID-19 treatment
por: Wang, Yan, et al.
Publicado: (2020)

Remote Health Monitoring in the Workplace for Early Detection of COVID-19 Cases during the COVID-19 Pandemic Using a Mobile Health Application: COVIDApp.
por: Echeverría, Patricia, et al.
Publicado: (2021)

A Cost–Benefit Analysis of COVID-19 Vaccination in Catalonia
por: López, Francesc, et al.
Publicado: (2021)

A Narrative Review of Antiviral Drugs Used for COVID-19 Pharmacotherapy
por: Kumar, Subodh, et al.
Publicado: (2021)

Novel modelling approaches to predict the role of antivirals in reducing influenza transmission
por: Asher, Jason, et al.
Publicado: (2023)

Surface Alterations to Impart Antiviral Properties to Combat COVID-19 Transmission
por: Siddiquie, Reshma Y., et al.
Publicado: (2020)

Analytical and clinical performance of the panbio COVID-19 antigen-detecting rapid diagnostic test
por: Alemany, Andrea, et al.
Publicado: (2021)

Is temperature reducing the transmission of COVID-19 ?
por: Tobías, Aurelio, et al.
Publicado: (2020)

Scoping insight on antiviral drugs against COVID-19
por: Ali, Ahmed S., et al.
Publicado: (2021)

Differential Transmission of Antiviral Drug-Resistant Chikungunya Viruses by Aedes Mosquitoes
por: Delang, Leen, et al.
Publicado: (2018)

Evidence-based dosing of convalescent plasma for COVID-19 in future trials
por: Rijnders, Bart J.A., et al.
Publicado: (2022)

A prospect on the use of antiviral drugs to control local outbreaks of COVID-19
por: Torneri, Andrea, et al.
Publicado: (2020)

Metabolomics to Predict Antiviral Drug Efficacy in COVID-19
por: Migaud, Marie, et al.
Publicado: (2020)

Antiviral Drug Discovery To Address the COVID-19 Pandemic
por: Richman, Douglas D.
Publicado: (2020)

Current Strategies of Antiviral Drug Discovery for COVID-19
por: Mei, Miao, et al.
Publicado: (2021)

Antiviral Drug Discovery for the Treatment of COVID-19 Infections
por: Ng, Teresa I., et al.
Publicado: (2022)

Association between mobility, non-pharmaceutical interventions, and COVID-19 transmission in Ghana: a modelling study using mobile phone data
por: Gibbs, Hamish, et al.
Publicado: (2021)

RNA editing by ADAR1 regulates innate and antiviral immune functions in primary macrophages
por: Pujantell, Maria, et al.
Publicado: (2017)

Drug-drug interaction with oral antivirals for the early treatment of COVID-19
por: Vuorio, Alpo, et al.
Publicado: (2023)

Effectiveness of potential antiviral treatments in COVID-19 transmission control: a modelling study
por: Lin, Sheng-Nan, et al.
Publicado: (2021)

Association between mobility, non-pharmaceutical interventions, and COVID-19 transmission in Ghana: A modelling study using mobile phone data
por: Gibbs, Hamish, et al.
Publicado: (2022)

Repurposing of antiviral drugs for COVID-19 and impact of repurposed drugs on the nervous system
por: Punekar, Madhura, et al.
Publicado: (2022)

Improvement of Severe COVID-19 in an Elderly Man by Sequential Use of Antiviral Drugs
por: Yatomi, Masakiyo, et al.
Publicado: (2020)

How to use COVID-19 antiviral drugs in patients with chronic kidney disease
por: Kale, Ajinath, et al.
Publicado: (2023)

A Trial of Three Rounds of Mass Drug Administration with Azithromycin for Yaws
por: John, Lucy N., et al.
Publicado: (2022)

Methylation regulation of Antiviral host factors, Interferon Stimulated Genes (ISGs) and T-cell responses associated with natural HIV control
por: Oriol-Tordera, Bruna, et al.
Publicado: (2020)

Drugs that reduce transmission of falciparum malaria
por: Price, Ric N, et al.
Publicado: (2018)

Union is strength: antiviral and anti-inflammatory drugs for COVID-19
por: Naveja, Jose J., et al.
Publicado: (2021)

Efficacy of repurposed antiviral drugs: Lessons from COVID-19
por: Martinez, Miguel Angel
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_c3lbbut6bp2sru4qh17eb6knu7